SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-305161
Filing Date
2023-12-28
Accepted
2023-12-28 16:06:03
Documents
15
Period of Report
2023-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d680407d8k.htm   iXBRL 8-K 41282
2 EX-4.1 d680407dex41.htm EX-4.1 118626
3 EX-10.1 d680407dex101.htm EX-10.1 348698
  Complete submission text file 0001193125-23-305161.txt   794279

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA engn-20231222.xsd EX-101.SCH 3582
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE engn-20231222_def.xml EX-101.DEF 13900
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE engn-20231222_lab.xml EX-101.LAB 23523
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE engn-20231222_pre.xml EX-101.PRE 14733
9 EXTRACTED XBRL INSTANCE DOCUMENT d680407d8k_htm.xml XML 6112
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 231522794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)